Speaker
Prof.
Zhibo Liu
(Peking University)
Summary
We developed a covalent FAP-targeted radiopharmaceutical, 99mTc-CTR-FAPI, and SPECT/CT showed comparable diagnostic capability to 18F-FDG PET/CT for detecting primary lung cancer lesions.
| Are you interested/eligible for the Young Session? | No, I am not eligible |
|---|
Authors
Dr
Mengxin Xu
(Changping Laboratory)
Prof.
Zhibo Liu
(Peking University)
